Invivyd, Inc.
corporate_fare Company Profile
Invivyd, Inc. (NASDAQ:IVVD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for IVVD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for IVVD spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Invivyd 10-Q: $126.4M Cash, Going-Concern Doubt, Nasdaq Bid Notice
- Invivyd Q3 Loss Widens to $33.5M; DECLARATION Data Now 'Imminent' After FDA Talks
- Invivyd Posts $33.5M Q3 Loss, $15.4M Revenue as Cash Concerns Linger
- VYD2311's Superior Safety in Phase 3 LIBERTY Paves Way for BLA Filing
- Invivyd's VYD2311 Shows Superior Safety vs mRNA Vaccine, BLA Filing Planned
Financial Snapshot
Short Interest & Short Volume
9.66 days to coverFINRA reported short interest of 36,204,545 shares in IVVD as of the October 30, 2026 settlement, a 2.3% decrease from the prior period — about 9.7 days to cover at its recent average daily volume. On November 20, 2026, 44.0% of IVVD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.